🇺🇸 Regular Insulin in United States

1,157 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 202 reports (17.46%)
  2. Nausea — 137 reports (11.84%)
  3. Pain — 131 reports (11.32%)
  4. Hypoglycaemia — 120 reports (10.37%)
  5. Renal Failure — 110 reports (9.51%)
  6. Blood Glucose Decreased — 100 reports (8.64%)
  7. Anxiety — 94 reports (8.12%)
  8. Vomiting — 92 reports (7.95%)
  9. Weight Decreased — 86 reports (7.43%)
  10. Injury — 85 reports (7.35%)

Source database →

Regular Insulin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Regular Insulin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Regular Insulin in United States?

University of Oklahoma is the originator. The local marketing authorisation holder may differ — check the official source linked above.